4.7 Article

The Medial Prefrontal Cortex Regulates the Differential Expression of Morphine-Conditioned Place Preference Following a Single Exposure to Controllable or Uncontrollable Stress

Journal

NEUROPSYCHOPHARMACOLOGY
Volume 34, Issue 4, Pages 834-843

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2008.34

Keywords

addiction; reward; resilience; learned helplessness; serotonin; rats

Funding

  1. US National Institute on Drug Abuse [DA013159, DA023329]

Ask authors/readers for more resources

Experiential factors, such as stress, are major determinants of vulnerability to drug addiction and relapse. The behavioral controllability of the stressor is a major determinant of how exposure to a stressor impacts addictive processes. Recent evidence suggests that controllable stressors, such as escapable shock (ES), activate ventral regions of the medial prefrontal cortex (mPFCv), whereas physically identical, but uncontrollable stress (inescapable shock, IS) does not. This activation is critical to the blunting effect that control has on neurochemical and behavioral sequelae of stress. Our laboratory has previously shown that IS, but not ES, potentiates morphine-conditioned place preference (CPP). However, the role of the mPFCv in this phenomenon is unknown. The present experiments investigated the role of the mPFCv during ES and IS in determining the effects of the stressor on subsequent morphine-CPP. Intra-mPFCv microinjection of the GABA(A) agonist muscimol 1 h before ES led ES to potentiate morphine-CPP, as does IS. Conversely, the potentiation of morphine-CPP normally observed in IS rats was blocked by intra-mPFCv microinjection of the GABAA antagonist picrotoxin 1 h before IS. These results suggest that during stress, activation of the mPFCv prevents subsequent potentiation of morphine-CPP, whereas inactivation of the mPFCv during stress does not. Thus, activation of the mPFCv during a stress experience is both necessary and sufficient to block the impact of stress on morphine-CPP, and control over stress blunts stress-induced potentiation of morphine effects by activating the mPFCv.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Phenotype-dependent inhibition of glutamatergic transmission on nucleus accumbens medium spiny neurons by the abused inhalant toluene

Jacob T. Beckley, Patrick K. Randall, Rachel J. Smith, Benjamin A. Hughes, Peter W. Kalivas, John J. Woodward

ADDICTION BIOLOGY (2016)

Article Neurosciences

The First Alcohol Drink Triggers mTORC1-Dependent Synaptic Plasticity in Nucleus Accumbens Dopamine D1 Receptor Neurons

Jacob T. Beckley, Sophie Laguesse, Khanhky Phamluong, Nadege Morisot, Scott A. Wegner, Dorit Ron

JOURNAL OF NEUROSCIENCE (2016)

Article Behavioral Sciences

Monoacylglycerol lipase inhibition alters social behavior in male and female rats after post-weaning social isolation

Jazmin Fontenot, Esteban C. Loetz, Matthew Ishiki, Sondra T. Bland

BEHAVIOURAL BRAIN RESEARCH (2018)

Article Chemistry, Medicinal

Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7

John V. Mulcahy, Hassan Pajouhesh, Jacob T. Beckley, Anton Delwig, J. Du Bois, John C. Hunter

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Developmental Biology

A novel social fear conditioning procedure alters social behavior and mTOR signaling in differentially housed adolescent rats

Lamya'a M. Dawud, Esteban C. Loetz, Brian Lloyd, Rachel Beam, Simon Tran, Kim Cowie, Kim Browne, Tassawwar Khan, Richard Montoya, Benjamin N. Greenwood, Sondra T. Bland

Summary: This study explored the impact of post-weaning social isolation (PSI) on conditioned social fear development, finding that PSI rats displayed a unique circling behavior that was enhanced after paired treatment. Furthermore, social behaviors were altered by both PSI and the paired footshock and social CS, with differences observed in the mTOR pathway between male and female rats.

DEVELOPMENTAL PSYCHOBIOLOGY (2021)

Article Psychology, Biological

Fructose and uric acid as drivers of a hyperactive foraging response: A clue to behavioral disorders associated with impulsivity or mania?

Richard J. Johnson, William L. Wilson, Sondra T. Bland, Miguel A. Lanaspa

Summary: This study suggests a link between fructose intake and behavioral disorders, proposing that high sugar and HFCS intake may cause hyperactive foraging responses that increase the risk for ADHD, bipolar disease, and aggressive behavior. Chronic stimulation of the pathway driven by high glycemic carbohydrates and sugars could lead to desensitization of hedonic responses and induce depression.

EVOLUTION AND HUMAN BEHAVIOR (2021)

Article Behavioral Sciences

Acute exercise enhances fear extinction through a mechanism involving central mTOR signaling

Nicolette A. Moya, Margaret K. Tanner, Abigail M. Smith, Aleezah Balolia, Jazmyne K. P. Davis, Kelsey Bonar, Jennifer Jaime, Troy Hubert, Jorge Silva, William Whitworth, Esteban C. Loetz, Sondra T. Bland, Benjamin N. Greenwood

NEUROBIOLOGY OF LEARNING AND MEMORY (2020)

Article Anesthesiology

Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain

Jacob T. Beckley, Hassan Pajouhesh, George Luu, Sheri Klas, Anton Delwig, Dennis Monteleone, Xiang Zhou, Denise Giuvelis, Ian D. Meng, David C. Yeomans, John C. Hunter, John Mulcahy

Summary: The voltage-gated sodium channel Na(v)1.7 plays a crucial role in pain signal transmission, making it a promising target for analgesic therapy. The small molecule Na(v)1.7 inhibitor ST-2530 demonstrated high selectivity for human Na(v)1.7 and exhibited potent analgesic effects in various mouse pain models, without affecting motor function.
Article Multidisciplinary Sciences

Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins

H. Pajouhesh, J. T. Beckley, A. Delwig, H. S. Hajare, G. Luu, D. Monteleone, X. Zhou, J. Ligutti, S. Amagasu, B. D. Moyer, D. C. Yeomans, J. Du Bois, J. V. Mulcahy

SCIENTIFIC REPORTS (2020)

Article Chemistry, Medicinal

SAGE-718: A First-in-Class N-Methyl-D-Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive Impairment

Matthew D. Hill, Maria-Jesus Blanco, Francesco G. Salituro, Zhu Bai, Jacob T. Beckley, Michael A. Ackley, Jing Dai, James J. Doherty, Boyd L. Harrison, Ethan C. Hoffmann, Tatiana M. Kazdoba, David Lanzetta, Michael Lewis, Michael C. Quirk, Albert J. Robichaud

Summary: NMDAR PAMs have emerged as a powerful mechanism for treating CNS disorders. The discovery of the endogenous neuroactive steroid 24(S)-hydroxycholesterol as an NMDAR PAM has led to the development of the oral drug candidate SAGE-718. This compound has shown promising results in phase 1 and is currently undergoing phase 2 clinical trials for the treatment of cognitive impairment in Huntington's disease.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery of Selective Inhibitors of NaV1.7 Templated on Saxitoxin as Therapeutics for Pain

Hassan Pajouhesh, Anton Delwig, Jacob T. Beckley, Sheri Klas, Dennis Monteleone, Xiang Zhou, George Luu, J. Du Bois, John C. Hunter, John V. Mulcahy

Summary: The voltage-gated sodium channel isoform Na(V)1.7 has been identified as a potential target for pain treatment, but selectivity over other related proteins has been a challenge. By utilizing a unique sequence variation in primate Na(V)1.7, a series of inhibitors have been discovered, with compound 25 exhibiting high selectivity and efficacy in a preclinical pain model.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Biochemistry & Molecular Biology

Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions

Weiting Tang, Jacob T. Beckley, Jin Zhang, Rui Song, Yuchen Xu, Sukhan Kim, Michael C. Quirk, Albert J. Robichaud, Eva Sarai Diaz, Scott J. Myers, James J. Doherty, Michael A. Ackley, Stephen F. Traynelis, Hongjie Yuan

Summary: N-methyl-D-aspartate receptors (NMDARs) are crucial for brain functions and neuropathological conditions. Endogenous neuroactive steroids and synthetic analogs derived from them enhance NMDAR function. This study explores their mechanism of action and their potential for treating NMDAR-related neuropsychiatric disorders.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Article Pharmacology & Pharmacy

Pharmacological characterization of SAGE-718, a novel positive allosteric modulator of N-methyl-d-aspartate receptors

Jacob T. Beckley, Teresa K. Aman, Michael A. Ackley, Tatiana M. Kazdoba, Michael C. Lewis, Anne C. Smith, Brandon J. Farley, Jing Dai, Wayne Deats, Ethan Hoffmann, Albert J. Robichaud, James J. Doherty, Michael C. Quirk

Summary: This study identified a neuroactive steroid NMDA receptor PAM called SAGE-718, which improves conditions associated with NMDA receptor hypofunction by increasing channel open probability.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Behavioral Sciences

Exercise increases mTOR signaling in brain regions involved in cognition and emotional behavior

Brian A. Lloyd, Holly S. Hake, Takayuki Ishiwata, Caroline E. Farmer, Esteban C. Loetz, Monika Fleshner, Sondra T. Bland, Benjamin N. Greenwood

BEHAVIOURAL BRAIN RESEARCH (2017)

No Data Available